Director · Summit Therapeutics Inc. (SMMT)

Yu (Michelle) Xia director compensation at Summit Therapeutics: $650K

Fiscal year 2025 director compensation for Yu (Michelle) Xia at Summit Therapeutics Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 17, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Yu (Michelle) Xia’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Yu (Michelle) Xia and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Summit Therapeutics Director Compensation Table · all 3 fiscal years held
In US dollars, as Summit Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$0$0$649,996$0$649,996
FY2023$0—$0—$0
FY2022—————

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Summit Therapeutics Inc. DEF 14A filed April 17, 2026, accession 0001599298-26-000029, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Summit Therapeutics Inc. filed document, accession 0001599298-26-000029. Every figure is read from that document and cited to the page and table it appears in. Filed April 17, 2026.

Get the Summit Therapeutics Board Governance Report

$649,996 Yu (Michelle) Xia, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 17, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

Summit Therapeutics pays directors a $49,900 cash retainer and $35,000 in Options.

The rest of the Summit Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Alessandra CesanoIndependent Director$640,181
Jeff HuberIndependent Director$649,186
Kenneth A. ClarkLead Independent Director$835,697
Mahkam ZanganehDirector—
Manmeet SoniDirector—
Mostafa RonaghiIndependent Director$625,486
Robert BoothIndependent Director$672,773
Robert W. DugganChair of the Board—

The full Summit Therapeutics compensation record

free company brief

This page is one director within Summit Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Order SMMT

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report